Genetic Testing Services Market

Genetic Testing Services Market - Global Market Share, Trends, Analysis and Forecast, 2023-2032
Frequently asked questions about this report

The genetic testing services market is expected to reach US$ 36.23 Billion by 2032

The genetic testing services market is expected to grow at a CAGR of 8.7% between 2023 to 2032.

The genetic testing services market was estimated to be US$ 15.73 Billion in 2022.

Europe is a prominent market for genetic testing services, driven by factors such as a growing geriatric population, increasing prevalence of genetic diseases, and the emphasis on precision medicine.

The oncology segment is expected to be one of the largest and most influential segments within the global genetic testing services market, driving advancements in cancer diagnosis, treatment, and management.

Abbott Laboratories (United States), Agilent Technologies (United States), BGI Genomics Co., Ltd. (China), Bio-Rad Laboratories, Inc. (United States), Eurofins Scientific (Luxembourg), F. Hoffmann-La Roche Ltd (Switzerland), Illumina, Inc. (United States), Laboratory Corporation of America Holdings (LabCorp) (United States), Myriad Genetics, Inc. (United States), Natera, Inc. (United States), NeoGenomics Laboratories, Inc. (United States), PerkinElmer, Inc. (United States), Quest Diagnostics Incorporated (United States), Thermo Fisher Scientific Inc. (United States), Veritas Genetics (United States) KP among others, are the major players in the genetic testing services market.

Genetic testing services are largely used in the Oncology, Cardiology, Neurology, Rare Diseases, Obstetrics & Gynecology, and other.